ₛₘₒₗ intern 💡
11.4K posts


Literally Solana looks so bad right now because of you bad actors No one wants to trade on this chain


Major update to Clarity Protocol We just shipped a full computational peptide discovery pipeline. Here's what that means: 1/ Clarity now has 6 autonomous AI agents running 24/7. The newest one mines bioactivity databases for known protein binders, designs novel candidate peptides targeting aggregation-prone regions, and scores them through multi-property drug-likeness filters. 2/ Every candidate peptide gets structural binding prediction; a computational measure of how strongly it binds the target protein. First batch scored in the "strong binding" range. These are computational predictions, not experimental results, but they tell us which candidates are worth testing in a real lab. 3/ The complex prediction daemon now processes protein-protein interaction jobs end-to-end. Queue a complex → structure prediction runs → results pushed to production. Currently predicting interaction structures relevant to Alzheimer's. 4/ 50+ folds across 13 proteins. Hundreds of candidate peptides designed and scored. Each one goes through bioactivity validation, structural analysis, and multi-gate screening. All visible on clarityprotocol.io. Some may still be processing. The next milestone is experimental validation; synthesizing top candidates and running real binding assays. The computational pipeline prioritizes what's worth testing. *A note on IP: All candidate peptide sequences on clarityprotocol.io are now redacted behind coded identifiers (CP-TAU-001, CP-SOD1-002, etc.). We show binding strength tiers, drug-likeness assessments, and target regions, but not the actual sequences. Raw data is stored locally and protected. If you're a researcher or wetlab interested in collaboration, reach out directly. We take IP seriously while keeping the platform open. *Filing for provisional patent *Architecture graph generalized to protect our methods

I get so many pitch decks now for peptide companies now and basically all of them 1) exclusively focus on their customer acquisition costs, their UGC/video content including AI generated marketing pipelines, and affiliate marketing strategy 2) talk about how fast their turnaround time is to patients and how broad their catalog of peptides are 3) do not talk at all about monitoring patients post prescription 4) they all say they work with the top suppliers to provide legitimacy but don't really have a clear methodology for how they're doing this (esp with so many steps between securing the in ingredient, to shipping, to compounding) I understand why peptides are popular - but I don't think having more companies who effectively are marketing/dropshipping companies while offloading liability and adverse events to the doctors is the right direction for healthcare



Pump fun will be the old thing While @printr will be the new and improved trench pad.. Glasses stay on!

I gotta be dead honest this project looks like the baddest larp dogshit I’ve ever witnessed but if it’s actually real an entry sub 100k seems extremely braindead worth the R/R


today I urged again to buy some undervalued defi shitters just to realize the devs don’t care about token price and just issue them to dump on your stupid little head




